News | Sutro Biopharma, Inc.

Sutro Biopharma to Present its Biochemical Protein Synthesis Technology at BioProduction Conference 2011 in Berlin

Sutro Biopharma to Present its Biochemical Protein Synthesis Technology at BioProduction Conference 2011 in Berlin SAN FRANCISCO, Oct. 17, 2011 – Sutro’s Chief Scientific Officer, Trevor Hallam, Ph.D., to Highlight Company’s Technology Platform for...

Study Shows Sutro Biopharma’s Biochemical Protein Synthesis Technology Enables Rapid Production and Scale-Up of Biopharmaceuticals Results Published in Biotechnology and Bioengineering Demonstrate that Cell-Free Production of a Biologically Active Human Cytokine Can be Scaled-up to Commercial Manufacturing Levels Study Featured in Journal’s Spotlight Section.

Press Releases

Study Shows Sutro Biopharma’s Biochemical Protein Synthesis Technology Enables Rapid Production and Scale-Up of Biopharmaceuticals Results Published in Biotechnology and Bioengineering Demonstrate that Cell-Free Production of a Biologically Active Human Cytokine...

Microscale to Manufacturing Scale-up of Cell-Free Cytokine Production: A New Approach for Shortening Protein Production Development Timelines

Presentations

Microscale to Manufacturing Scale-up of Cell-Free Cytokine Production: A New Approach for Shortening Protein Production Development Timelines James F. Zawada, Gang Yin, Alexander R. Steiner, Junhao Yang, Alpana Naresh, Sushmita M. Roy, Daniel S. Gold, Henry G....

Microscale to Manufacturing Scale-up of Cell-Free Cytokine Production: A New Approach for Shortening Protein Production Development Timelines

Events

Microscale to Manufacturing Scale-up of Cell-Free Cytokine Production: A New Approach for Shortening Protein Production Development Timelines PHARMACEUTICAL TECHNOLOGY Volume 35, pp. s8-s11 Industrializing Design, Development, and Manufacturing of Therapeutic Proteins...

“Unnatural Selection”

Events

“Unnatural Selection” BioCentury, The Bernstein Report on BioBusiness January 10, 2011 issue article, “Unnatural Selection” in the Tools & Techniques section by BioCentury Senior Editor, Ms. Susan Schaeffer. Read...

Sutro Biopharma Forges Partnership with Pfizer for Discovery, Development and Commercialization of Novel Peptide-Based Therapeutics. Company’s First Major Collaboration Validates Potential of Biochemical Protein Synthesis Technology Platform.

Press Releases

Sutro Biopharma Forges Partnership with Pfizer for Discovery, Development and Commercialization of Novel Peptide-Based Therapeutics. Company’s First Major Collaboration Validates Potential of Biochemical Protein Synthesis Technology Platform. San Francisco, CA...

« Older Entries

Next Entries »